Fortrea Holdings Inc. SEC filings FTRE
Fortrea Holdings Inc. has 338 filings in SEC EDGAR's recent list, going back to Feb 13, 2023. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 29, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 29, 2026 | Oct 29, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 30, 2026 | Sep 29, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 10, 2026 | Sep 9, 2026 |
| 10-Q | Quarterly report | Jul 29, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Jul 29, 2026 | Jul 27, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 14, 2026 | Jul 8, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 26, 2026 | Jun 26, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2026 | Jun 9, 2026 |
| 10-Q | Quarterly report | May 5, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 5, 2026 | May 5, 2026 |
| ARS | Annual report to shareholders | Apr 27, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 27, 2026 | — |
| DEF 14A | Proxy statement | Apr 27, 2026 | Jun 9, 2026 |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2026 | Feb 26, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 20, 2025 | Nov 18, 2025 |
| 10-Q | Quarterly report | Nov 5, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2025 | Nov 5, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 22, 2025 | Sep 19, 2025 |
| S-8 | Employee stock plan registration | Aug 29, 2025 | — |
| S-8 | Employee stock plan registration | Aug 29, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Aug 27, 2025 | Aug 21, 2025 |
| 10-Q | Quarterly report | Aug 6, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2025 | Aug 6, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 12, 2025 | Jun 10, 2025 |
| 8-A12B | Filing | Jun 12, 2025 | — |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Jun 12, 2025 | Jun 11, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 11, 2025 | Jun 11, 2025 |
| 8-K/A |
Amended current report
Officer or director change
|
May 15, 2025 | Mar 5, 2025 |
| DEFA14A | Additional proxy material | May 15, 2025 | — |
| 10-Q | Quarterly report | May 12, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 12, 2025 | May 12, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure, Other events
|
May 12, 2025 | May 9, 2025 |
| ARS | Annual report to shareholders | Apr 28, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 28, 2025 | — |
| DEF 14A | Proxy statement | Apr 28, 2025 | Jun 10, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 10, 2025 | Mar 5, 2025 |
| 10-K | Annual report | Mar 3, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 3, 2025 | Mar 3, 2025 |
| 8-K |
Current report
Material agreement, Officer or director change, Regulation FD disclosure
|
Feb 21, 2025 | Feb 21, 2025 |
| 10-Q | Quarterly report | Nov 8, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2024 | Nov 8, 2024 |
| 8-K/A |
Amended current report
Officer or director change
|
Aug 26, 2024 | May 14, 2024 |
| 10-Q | Quarterly report | Aug 12, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2024 | Aug 12, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 11, 2024 | Jul 8, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 20, 2024 | Jun 14, 2024 |
| 8-K/A |
Amended current report
Regulation FD disclosure
|
Jun 7, 2024 | May 24, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 4, 2024 | Jun 3, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
May 24, 2024 | May 24, 2024 |
| 10-Q | Quarterly report | May 24, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Regulation FD disclosure
|
May 16, 2024 | May 14, 2024 |
| NT 10-Q | Filing | May 15, 2024 | May 15, 2024 |
| 8-K |
Current report
Results of operations
|
May 13, 2024 | May 13, 2024 |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure
|
May 9, 2024 | May 3, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 1, 2024 | Mar 30, 2024 |
| ARS | Annual report to shareholders | Mar 28, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Mar 28, 2024 | — |
| DEF 14A | Proxy statement | Mar 28, 2024 | May 14, 2024 |
| 10-K | Annual report | Mar 13, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 11, 2024 | Mar 11, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 29, 2023 | Nov 27, 2023 |
| 8-K |
Current report
Other events
|
Nov 21, 2023 | Nov 21, 2023 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2023 | Nov 13, 2023 |
| 8-K/A |
Amended current report
Results of operations
|
Aug 24, 2023 | Aug 14, 2023 |
| 8-K |
Current report
Officer or director change
|
Aug 21, 2023 | Aug 17, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 14, 2023 | Aug 14, 2023 |
| 8-K |
Current report
Material agreement, New debt, Change in control, Officer or director change, Bylaw or fiscal year change, Other events
|
Jul 3, 2023 | Jun 29, 2023 |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure
|
Jun 30, 2023 | Jun 27, 2023 |
| S-8 | Employee stock plan registration | Jun 29, 2023 | — |
| 8-K |
Current report
Officer or director change
|
Jun 21, 2023 | Jun 15, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 12, 2023 | Jun 12, 2023 |
| SEC STAFF ACTION | Filing | Jun 9, 2023 | — |
| CERT | Filing | Jun 9, 2023 | — |
| CORRESP | Letter to the SEC | Jun 8, 2023 | — |
| CORRESP | Letter to the SEC | Jun 8, 2023 | — |
| 10-12B/A | Filing | Jun 8, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 7, 2023 | — |
| 10-12B/A | Filing | Jun 2, 2023 | — |
| CORRESP | Letter to the SEC | Jun 2, 2023 | — |
| UPLOAD | Letter from the SEC | May 25, 2023 | — |
| CORRESP | Letter to the SEC | May 15, 2023 | — |
| 10-12B | Filing | May 15, 2023 | — |
| UPLOAD | Letter from the SEC | Apr 19, 2023 | — |
| DRSLTR | Filing | Apr 5, 2023 | — |
| DRS/A | Filing | Apr 5, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 13, 2023 | — |
| DRSLTR | Filing | Feb 13, 2023 | — |
| DRS | Filing | Feb 13, 2023 | — |
Showing 93 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- FTRE (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Durham, NC
- SEC filer status
- Accelerated filer
- SEC CIK
- 1965040
- Former names
- Silver Spinco Inc. (until Apr 5, 2023)
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.